For research use only. Not for therapeutic Use.
Triperiden(Cat No.:M062390)is an anticholinergic medication primarily used to manage symptoms of Parkinson’s disease and to relieve extrapyramidal side effects caused by certain antipsychotic drugs. It works by blocking acetylcholine receptors, helping to reduce muscle stiffness, tremors, and spasms associated with Parkinsonian symptoms. Triperiden’s action on the central nervous system restores a better balance between dopamine and acetylcholine, alleviating motor dysfunction. While beneficial in reducing motor symptoms, it can have side effects like dry mouth, blurred vision, and constipation, requiring careful dosing and monitoring for optimal safety and effectiveness.
Catalog Number | M062390 |
CAS Number | 14617-17-5 |
Synonyms | triperiden |
Molecular Formula | C21H30ClNO |
Purity | ≥95% |
Target | Influenza Virus |
Storage | Store at -20°C |
IUPAC Name | 1-phenyl-3-piperidin-1-yl-1-(3-tricyclo[2.2.1.02,6]heptanyl)propan-1-ol;hydrochloride |
InChI | InChI=1S/C21H29NO.ClH/c23-21(16-7-3-1-4-8-16,9-12-22-10-5-2-6-11-22)20-15-13-17-18(14-15)19(17)20;/h1,3-4,7-8,15,17-20,23H,2,5-6,9-14H2;1H |
InChIKey | HWSIZQMXQQXDNZ-UHFFFAOYSA-N |
SMILES | C1CCN(CC1)CCC(C2C3CC4C2C4C3)(C5=CC=CC=C5)O.Cl |